Abstract:Circulation Research, Ahead of Print. BACKGROUND:Angiogenesis, which plays a critical role in embryonic development and tissue repair, is controlled by a set of angiogenic signaling pathways. As a TF (transcription factor) belonging to the basic helix-loop-helix family, HEY (hairy/enhancer of split related with YRPW motif)-1 has been identified as a key player in developmental angiogenesis. However, the precise mechanisms underlying HEY1's actions in angiogenesis remain largely unknown. Our previous studies have suggested a potential role for posttranslational SUMOylation in the dynamic regulation of vascular development and organization.METHODS:Immunoprecipitation, mass spectrometry, and bioinformatics analysis were used to determine the biochemical characteristics of HEY1 SUMOylation. The promoter-binding capability of HEY1 was determined by chromatin immunoprecipitation, dual luciferase, and electrophoretic mobility shift assays. The dimerization pattern of HEY1 was determined by coimmunoprecipitation. The angiogenic capabilities of endothelial cells were assessed by CCK-8, 5-ethynyl-2-deoxyuridine staining, wound healing, transwell, and sprouting assays. Embryonic and postnatal vascular growth in mouse tissues, matrigel plug assay, cutaneous wound healing model, oxygen-induced retinopathy model, and tumor angiogenesis model were used to investigate the angiogenesis in vivo.RESULTS:We identified intrinsic endothelial HEY1 SUMOylation at conserved lysines by TRIM28 (tripartite motif containing 28) as the unique E3 ligase. Functionally, SUMOylation facilitated HEY1-mediated suppression of angiogenic RTK (receptor tyrosine kinase) signaling and angiogenesis in primary human endothelial cells and mice with endothelial cell–specific expression of wild-type HEY1 or a SUMOylation-deficient HEY1 mutant. Mechanistically, SUMOylation facilitates HEY1 homodimer formation, which in turn preserves HEY1's DNA-binding capability via recognition of E-box promoter elements. Therefore, SUMOylation maintains HEY1's function as a repressive TF controlling numerous angiogenic genes, including RTKs and Notch pathway components. Proangiogenic stimuli induce HEY1 deSUMOylation, leading to heterodimerization of HEY1 with HES (hairy and enhancer of split)-1, which results in ineffective DNA binding and loss of HEY1's angiogenesis-suppressive activity.CONCLUSIONS:Our findings demonstrate that reversible HEY1 SUMOylation is a molecular mechanism that coordinates endothelial angiogenic signaling and angiogenesis, both in physiological and pathological milieus, by fine-tuning the transcriptional activity of HEY1. Specifically, SUMOylation facilitates the formation of the HEY1 transcriptional complex and enhances its DNA-binding capability in endothelial cells.

SUMOylated NICD in Endothelial Cell Suppresses Tumor Angiogenesis

SUMOylation Negatively Regulates Angiogenesis by Targeting Endothelial NOTCH Signaling.

FGFR1 SUMOylation Coordinates Endothelial Angiogenic Signaling in Angiogenesis

Suppression of VEGFD expression by S-nitrosylation promotes the development of lung adenocarcinoma

Sumoylation of EphB1 Suppresses Neuroblastoma Tumorigenesis Via Inhibiting PKCγ Activation

SUMOylation of Vascular Endothelial Growth Factor Receptor 2 Inhibits the Proliferation, Migration, and Angiogenesis Signaling Pathway in Non-Small Cell Lung Cancer

Suppression of Angiogenesis and Tumor Growth by Selective Inhibition of Angiopoietin-2

The Significance of SUMOylation of Angiogenic Factors in Cancer Progression

Inactivation of Endothelial ZEB1 Impedes Tumor Progression and Sensitizes Tumors to Conventional Therapies.

Knockdown of Endothelial NOS by Lentivirus-Mediated Short Hairpin RNA in Hemangioendothelioma Cells Increases Proliferation and Tumor Formation

Abstract 23: Microrna302-367 Sphingosine 1 Phosphate Receptor 1 Pathway Prevents Tumor Growth Via Restricting Angiogenesis and Enhancing Vascular Stability

SUMO-specific Protease 1 Regulates the in Vitro and in Vivo Growth of Colon Cancer Cells with the Upregulated Expression of CDK Inhibitors.

Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth

Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling.

Direct Demonstration Of Negative Regulation Of Tumor Growth And Metastasis By Host-Inducible Nitric Oxide Synthase

SUMOylation Fine-Tunes Endothelial HEY1 in the Regulation of Angiogenesis

SENP1-mediated SUMOylation of SIRT1 affects glioma development through the NF-κB pathway

Endothelial miR-30c suppresses tumor growth via inhibition of TGF-&bgr;–induced Serpine1

SUMOylation of IGF2BP2 Promotes Vasculogenic Mimicry of Glioma Via Regulating OIP5-AS1/miR-495-3p Axis

Inactivation of endothelial cell phosphoinositide 3-kinase β inhibits tumor angiogenesis and tumor growth

Nod1-Dependent Control Of Tumor Growth